Non-opioid Pain Patch Market Share

  • Report ID: 5423
  • Published Date: Sep 11, 2025
  • Report Format: PDF, PPT

Non-opioid Pain Patch Market Regional Analysis:

North American Market Insights

Non-opioid pain patch market in North America is predicted to account for the largest share of 51% by 2035 propelled by the presence of key players which has led to the development of new products. For instance, in October 2020 Vizuri Health Sciences Consumer Healthcare Inc. an innovative healthcare facility in Maryland, USA, launched a groundbreaking New Pain Relief PatchBloc24 Flexi-Stretch Pain Tape with 4-way stretch fabric and potent anesthetic to numb the pain, making it perfect for use on moving joints, including elbows and knees.

European Market Insights

The Europe non-opioid pain patch market is estimated to be the second largest, during the forecast timeframe led by a higher prevalence of stress. For instance, Greece has over 6% frequency of depression in Europe, and more than 55% of people in the country are reported to have frequent stress. This may drive the demand for non-opioid pain patch in the region since people with stress usually experience migraine which causes pain behind one eye or in the area surrounding the temples and lasts for hours or days.

Non-opioid-Pain-Patches-Market-size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of non-opioid pain patch is estimated at USD 1.06 billion.

The global non-opioid pain patch market size crossed USD 998.64 million in 2025 and is likely to expand at a CAGR of over 6.4%, surpassing USD 1.86 billion revenue by 2035.

North America’s non-opioid pain patch market dominates with a 51% share by 2035, driven by the presence of key players leading to the development of new products.

Key players in the market include GlaxoSmithKline Plc., Pfizer Inc., Hisamitsu Pharmaceutical Co., Inc., Clarion Brands, Endo Pharmaceuticals, TEH SENG Pharmaceutical, Teva Pharmaceutical Industries Ltd., Teikoku Seiyaku Co. Ltd., Veridian Healthcare, Sorrento Therapeutics (SCILEX Pharmaceuticals Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos